Xcout Intel
Elevian, Inc.
Elevian, Inc. is a biotechnology research company dedicated to developing new medicines that promote recovery and regeneration.
Subscribe to see Elevian, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Elevian, Inc. at a glance
Elevian, Inc. is a health & life sciences company headquartered in United States. Its most recent funding round raised $22.7M in August 2021. Xcout tracks 4 named people at Elevian, Inc., including Mark Allen (Co-Founder & CEO).
Elevian, Inc. leadership
- Mark AllenCo-Founder & CEO
- Tony SandrasagraSVP, Research & Development
- Manisha SinhaSr. Director, Discovery & Preclinical
- Christopher DaleHead, Protein Manufacturing & CMC
Elevian, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $22.7M | — | |
| Series A | $40M | 8 named | |
| SEC Form D filing | $15.3M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Get Elevian, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Elevian, Inc. in Xcout Intel
- 4 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access